**Question:** Dermatomyositis test of choice -

A. Antinuclear Antibody (ANA) Test
B. Rhabdomyolysis Test
C. Muscle Biopsy
D. Electromyography (EMG) Test

**Correct Answer:** C. Muscle Biopsy

**Core Concept:**
Dermatomyositis is a rare autoimmune disorder characterized by inflammation and damage to the muscles, skin, and sometimes internal organs. The diagnosis of dermatomyositis is based on clinical features, laboratory tests, and supportive evidence obtained from various diagnostic tests.

**Why the Correct Answer is Right:**
The correct answer, Muscle Biopsy, is chosen as the test of choice for dermatomyositis diagnosis because it provides direct evidence of muscle inflammation and damage. Muscle biopsy allows for histopathological examination of muscle fibers, revealing the hallmark findings of dermatomyositis, such as perifascicular atrophy (loss of muscle fibers around the fascia) and the presence of inflammatory cells and myofiber necrosis. These findings support the diagnosis of dermatomyositis, which is crucial for accurate diagnosis and treatment.

**Why Each Wrong Option is Incorrect:**

A. Antinuclear Antibody (ANA) Test: While ANA testing is a helpful initial screening test for autoimmune disorders, including dermatomyositis, it is not specific enough to confirm the diagnosis. ANA is positive in multiple autoimmune conditions, making it insufficient as a standalone test for dermatomyositis.

B. Rhabdomyolysis Test: Rhabdomyolysis is a condition characterized by the breakdown of muscle fibers leading to release of myoglobin into the bloodstream, causing elevated serum creatine kinase (CK) levels. While elevated CK levels may be seen in dermatomyositis, performing a rhabdomyolysis test alone is insufficient for diagnosing dermatomyositis because many other conditions can cause elevated CK levels.

D. Electromyography (EMG): EMG is a useful test to assess muscle function and detect neuromuscular disorders. While EMG can provide information about muscle function and detect neuromuscular disorders, it does not directly demonstrate muscle inflammation and damage, which is crucial for diagnosing dermatomyositis.

**Clinical Pearl:**
Dermatomyositis is a critical clinical diagnosis to rule out as it can lead to misdiagnosis and inappropriate treatment. A comprehensive approach to diagnose dermatomyositis involves clinical assessment, laboratory tests, and supportive evidence like muscle biopsy.